Clinical Trial Update: Dendritic Cell Based Therapy of Malignant Melanoma [Phase 1, Phase 2]

View source ↗

Summary

A dendritic cell–based therapy for advanced melanoma has completed Phase 1 and Phase 2 trials.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Dendritic cell-based therapy

Snippet

Sponsor: Herlev Hospital | Conditions: Advanced Melanoma | Phase 1, Phase 2 | Status: COMPLETED